| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 09/11/2001 | US6287853 Genetically engineered escherichia plasmid; marking antibiotic resistance; artificial chromosomes; genetic mapping |
| 09/11/2001 | US6287574 Proteinase K resistant surface protein of neisseria meningitidis |
| 09/11/2001 | US6287539 Methods of imaging using osmotically stabilized microbubble preparations |
| 09/11/2001 | US6287538 DTPA monoamides, pharmaceutical agents containing these compounds, their use and process for their production |
| 09/11/2001 | US6286319 Meted hyperpolarized noble gas dispensing methods and associated devices |
| 09/11/2001 | CA2186382C Method and apparatus for diagnosing erectile dysfunction |
| 09/11/2001 | CA2020368C Angiographic adjuvant |
| 09/07/2001 | WO2001064874A2 Low density liprotein binding proteins and their use in diagnosing and treating atherosclerosis |
| 09/07/2001 | WO2001064743A1 GPib-LIPID BOND CONSTRUCT AND USE THEREOF |
| 09/07/2001 | WO2001064708A1 Bile acids conjugates with metal ion chelates and the use thereof |
| 09/07/2001 | WO2001064660A1 Novel quinoline ligands and metal complexes for diagnosis and therapy |
| 09/07/2001 | WO2001064255A1 Method for detecting and killing epithelial cancer cells |
| 09/07/2001 | WO2001064110A1 Method for detecting and killing epithelial cancer cells |
| 09/07/2001 | WO2001064031A2 Slpi knockout mice and methods for wound treatment |
| 09/07/2001 | WO2000071166A3 Process |
| 09/07/2001 | CA2370741A1 Method for detecting and killing epithelial cancer cells |
| 09/06/2001 | US20010020098 For labeling target molecules |
| 09/06/2001 | US20010019710 Contrast agents |
| 09/06/2001 | US20010018919 Method, apparatus and system for use in treating patient with a drug having an antineoplastic effect to optimize therapy and prevent an adverse drug response |
| 09/05/2001 | EP1128848A1 A novel method of diagnosing, monitoring, staging and treating gynecological and prostatic cancers |
| 09/05/2001 | EP1128812A1 Nano-emulsion of 5-aminolevulinic acid |
| 09/05/2001 | EP1128784A1 Therapeutic use of polymers |
| 09/05/2001 | EP0804162B1 Butylene oxide-ethylene oxide block copolymer surfactants as stabilizer coatings for nanocrystal formulation |
| 09/05/2001 | CN1311694A Drugs for therapeutic use enabling nuclear magnetic resonance diagnosis by scalar bond |
| 09/04/2001 | US6284532 Purified human papillomavirus |
| 09/04/2001 | US6284476 Method of identifying individuals suffering from a cellular abnormality some of whose abnormal cells present complexes of human leukocyte antigen/tyrosinase derived peptides, and methods for treating said individuals |
| 09/04/2001 | US6284375 Useful in variety of biomedical applications including drug delivery, vaccine targeting, drug distribution and uptake, membrane protein reconstitution, enzyme immobilization and construction of artificial cells such as blood cells |
| 09/04/2001 | US6284280 Microparticles containing active ingredients, agents containing these microparticles, their use for ultrasound-controlled release of active ingredients, as well as a process for their production |
| 09/04/2001 | US6284239 Murine model for human carcinoma |
| 09/04/2001 | US6284223 Diagnosis, surgery |
| 09/04/2001 | US6284222 Hyperpolarized helium-3 microbubble gas entrapment methods |
| 09/04/2001 | US6284220 Noninvasive imaging of nucleic acid vectors |
| 09/04/2001 | US6284219 In vivo determination of metabolic function for use in therapy management |
| 09/04/2001 | US6282920 Via injecting helium (or isotopes) into an optical pumping cell, liquefying the polarized gas, and storing in tank which has means of alternatively communicating with pumping cell and high pressure gas discharge duct; nuclear magnetic resonance |
| 09/04/2001 | CA1341289C Amide complexes |
| 08/30/2001 | WO2001063291A1 Immunoassay method for the diagnosis of gastric intestinal metaplasia associated with gastric carcinoma |
| 08/30/2001 | WO2001063290A1 Bcmp-7 as marker for diagnosis of breast cancer |
| 08/30/2001 | WO2001063289A1 Diagnosis of breast cancer using bcmp-11 as marker |
| 08/30/2001 | WO2001063288A1 Diagnosis of breast cancer using bcmp-81 as marker |
| 08/30/2001 | WO2001062914A1 Bcmp 84, a protein associated to breast cancer |
| 08/30/2001 | WO2001062784A2 Use of breast cancer associated membrane proteins (bcmp) for treatment, prophylaxis and diagnosis of breast cancer |
| 08/30/2001 | WO2001062297A1 Compositions and methods for enhancing drug delivery across biological membranes and tissues |
| 08/30/2001 | WO2001062243A1 Method of treating and diagnosing sleep disordered breathing and means for carrying out the method |
| 08/30/2001 | WO2001062156A1 Novel indocyanine dyes |
| 08/30/2001 | WO2000040597A9 Method and composition for angiogenesis inhibition |
| 08/30/2001 | US20010018509 Growth differeniation factor-3 |
| 08/30/2001 | US20010018421 Polypeptides |
| 08/30/2001 | US20010018420 Method for alleviating pain or providing an analgesic effect in a patient |
| 08/30/2001 | US20010018042 Animal model for detection of vulnerable plaques |
| 08/30/2001 | CA2671940A1 Identification of partial agonists of the a2a adenosine receptor |
| 08/30/2001 | CA2400669A1 Immunoassay method for the diagnosis of gastric intestinal metaplasia associated with gastric carcinoma |
| 08/30/2001 | CA2400099A1 Compositions and methods for enhancing drug delivery across biological membranes and tissues |
| 08/30/2001 | CA2399999A1 Use of breast cancer associated membrane proteins (bcmp) for treatment, prophylaxis and diagnosis of breast cancer |
| 08/29/2001 | EP1127355A1 Products and methods for brachytherapy |
| 08/29/2001 | EP1127119A1 Compounds and methods for modulating claudin-mediated functions |
| 08/29/2001 | EP1126884A2 Radiodense compositions |
| 08/29/2001 | EP1126883A1 Hyperpolarized helium-3 microbubble gas entrapment methods |
| 08/29/2001 | EP1126877A1 Method of diagnosing, monitoring, staging, imaging and treating prostate cancer |
| 08/29/2001 | EP1126788A2 System and method for radiographic imaging of tissue |
| 08/29/2001 | EP1126785A1 Manganese compositions and methods for mri |
| 08/29/2001 | EP1126782A1 Method for improved imaging and photodynamic therapy |
| 08/28/2001 | US6281263 Methods for embolizing blood vessels |
| 08/28/2001 | US6280935 Method of detecting the presence or absence of a plurality of target sequences using oligonucleotide tags |
| 08/28/2001 | US6280706 Chelating agents |
| 08/28/2001 | US6280705 Kits & systems for ultrasonic imaging |
| 08/28/2001 | US6280704 Microbubbles osmotically stabilized with perfluorocarbon gas |
| 08/28/2001 | US6280703 Simultaneous multimodal measurement of physiological function |
| 08/28/2001 | US6280702 Endoscopy tissue stain |
| 08/23/2001 | WO2001061055A2 Methods for diagnosing, monitoring, staging, imaging and treating lung cancer via lung cancer specific genes |
| 08/23/2001 | WO2001060820A2 Matrix metalloproteinase inhibitors and uses thereof |
| 08/23/2001 | WO2001060416A2 Matrix metalloproteinase inhibitors as targeting components in diagnostic agents |
| 08/23/2001 | WO2001025399A3 Non-invasive tumor imaging by tumor-targeted bacteria |
| 08/23/2001 | WO2000074727A3 Radiopharmaceuticals and methods for imaging |
| 08/23/2001 | US20010016760 Use of 5-aminolevulinic acid or a derivate thereof for photodynamic diagnosis and/or photodynamic therapy |
| 08/23/2001 | US20010016587 Contrast agents |
| 08/23/2001 | US20010016196 Immunoliposomes that optimize internalization into target cells |
| 08/23/2001 | DE10006570A1 Nicht toxisches MR-Kontrastmittel Non-toxic MR contrast agents |
| 08/23/2001 | CA2395841A1 Matrix metalloproteinase inhibitors and uses thereof |
| 08/23/2001 | CA2395038A1 Matrix metalloproteinase inhibitors |
| 08/22/2001 | EP1125577A2 Liquid drug delivery compositions |
| 08/22/2001 | EP1124957A1 Pholasin |
| 08/22/2001 | EP1124790A1 Biodegradable nonionic contrast media |
| 08/22/2001 | EP1124580A1 Enhanced radiation therapy |
| 08/22/2001 | EP1124538A2 Composition for the parenteral administration of active agents |
| 08/22/2001 | EP0726781B1 In vivo agents comprising radioactive metal-ion chelates with acidic saccharides and glycosaminoglycans, giving improved site-selective localization, uptake mechanism, sensitivity and kinetic-spatial profiles |
| 08/22/2001 | CN1309720A Virulence-associated nucleic acid sequences and uses thereof |
| 08/22/2001 | CN1309661A Labelled glutamine and lysine analogues |
| 08/22/2001 | CN1069838C Stable microbubble suspensions as enhancement agent for ultrasound echography |
| 08/22/2001 | CN1069825C Aqueous demethyl coclaurine injection for diagnosis of coronary heart disease |
| 08/21/2001 | US6278893 Method of magnetic resonance imaging of a sample with ex vivo polarization of an MR imaging agent |
| 08/21/2001 | US6278892 Method and apparatus for administration of contrast agents for use in magnetic resonance arteriography |
| 08/21/2001 | US6278040 Receptor-deficient mice and cell lines derived therefrom, and uses thereof |
| 08/21/2001 | US6278039 C. elegans deletion mutants |
| 08/21/2001 | US6277841 Quinoline ligands and metal complexes for diagnosis and therapy |
| 08/21/2001 | US6277818 Cyclic peptide ligands that target urokinase plasminogen activator receptor |
| 08/21/2001 | CA2060652C N-substituted cycloalkyl and polycycloalkyl alpha-substituted trp-phe- and phenethylamine derivatives |
| 08/16/2001 | WO2001059452A2 Method for diagnosing efficacy of xenotypic antibody therapy |
| 08/16/2001 | WO2001058927A1 Therapeutic and diagnostic methods for ulcerative colitis and associated disorders |
| 08/16/2001 | WO2001058434A2 Diagnostic and therapeutic compositions and methods for affecting tumor growth using oxygen mimetic agents |
| 08/16/2001 | WO2000076551A3 Method for producing an injectable medicament preparation |